Verve Therapeutics, Inc. (VERV) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 4 Buy, 8 Hold, 1 Sell.
The consensus price target is $15.00, representing an upside of 34.8% from the current price $11.13.
VERV Stock — 12-Month Price Forecast
$15.00
▲ +34.77% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for Verve Therapeutics, Inc., the price target is $15.00.
The average price target represents a +34.77% change from the last price of $11.13.
VERV Analyst Ratings
Hold
Based on 13 analysts giving stock ratings to Verve Therapeutics, Inc. in the past 3 months
